Joanne Palmer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 06/10/2010 | - |
| Director/Board Member | - | - |
Career history of Joanne Palmer
Former positions of Joanne Palmer
| Companies | Position | Start | End |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | - | - |
Statistics
International
| United Kingdom | 3 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Joanne Palmer
- Experience
